FAKTOR OPTIONSSCHEIN - INCYTE CO. Share Price

DE000GG732D9

Market Closed - BOERSE MUENCHEN 19:25:38 07/06/2024 BST
26.14 ^EUR	+16.02%

Current month	+25.61%
1 month	+76.74%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	06-07	BU
Incyte Completes Acquisition of Escient Pharmaceuticals	05-30	BU
Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	05-23	MT
Incyte Acquires 2 Office Buildings in Delaware	05-21	MT

More news

Quotes 5-day view

Date	Price	Change
07/06/24	26.14	+16.02%
06/06/24	22.53	-13.68%
05/06/24	26.1	-4.92%
04/06/24	27.45	+7.35%
03/06/24	25.57	+22.87%

Real-time BOERSE MUENCHEN

Last update June 07, 2024 at 07:25 pm

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Goldman Sachs
WKN	GG732D
ISIN	DE000GG732D9
Date issued	26/04/2024
Strike	53.92 $
Maturity	Unlimited
Parity	0.18 : 1
Emission price	8.66 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	27.66 €
Lowest since issue	6.83 €
Spread	0.5 €
Spread %	1.85%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

59.16 USD

Average target price

72.8 USD

Spread / Average Target

+23.06%

Consensus